Delayed diagnoses due to pandemic lockdowns tied to years of life lost

FDA grants accelerated approval for the first T cell therapy for a solid tumor cancer

Exposure-adjusted incidence rates similar at one, two years for adverse events in patients with moderate-to-severe plaque psoriasis

Median time interval after the previous cutaneous squamous cell carcinoma decreases after each subsequent cutaneous squamous cell carcinoma

Significant reductions seen in mean Physician Global Assessment scores and in pain, C-reactive protein, IL-6, leukocytes

Both specialists and generalists were 4 percentage points less accurate for diagnosis of images of dark versus light skin

• sNDA is supported by positive data from the Phase 3 ADORING 1 and ADORING 2 pivotal trials and interim results from the Phase 3...

Newly approved medication lowers the need for amputation of fingers or toes

Disparities seen in access to burn centers, with lower access in the South and West and for those with lower income